These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23470080)

  • 21. Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure.
    Tentzeris I; Jarai R; Farhan S; Perkmann T; Schwarz MA; Jakl G; Wojta J; Huber K
    Eur J Heart Fail; 2011 Jul; 13(7):726-33. PubMed ID: 21616953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential Clinical Utility of Copeptin (C-terminal provasopressin) measurements in clinical medicine.
    Lewandowski KC; Brabant G
    Exp Clin Endocrinol Diabetes; 2016 Mar; 124(3):173-7. PubMed ID: 27008633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Copeptin in acute coronary syndromes and heart failure management: State of the art and future directions.
    Schurtz G; Lamblin N; Bauters C; Goldstein P; Lemesle G
    Arch Cardiovasc Dis; 2015; 108(6-7):398-407. PubMed ID: 26071835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of hyponatremia and elevated copeptin with death and need for transplantation in ambulatory patients with chronic heart failure.
    Miller WL; Grill DE; Struck J; Jaffe AS
    Am J Cardiol; 2013 Mar; 111(6):880-5. PubMed ID: 23276468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study.
    Maisel A; Xue Y; Shah K; Mueller C; Nowak R; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand IS; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
    Circ Heart Fail; 2011 Sep; 4(5):613-20. PubMed ID: 21765124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular Mortality in Chest Pain Patients: Comparison of Natriuretic Peptides With Novel Biomarkers of Cardiovascular Stress.
    Sinning C; Ojeda F; Zeller T; Zengin E; Rupprecht HJ; Lackner KJ; Bickel C; Blankenberg S; Schnabel RB; Westermann D
    Can J Cardiol; 2016 Dec; 32(12):1470-1477. PubMed ID: 27568502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Copeptin in Heart Failure.
    Balling L; Gustafsson F
    Adv Clin Chem; 2016; 73():29-64. PubMed ID: 26975969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Copeptin: a biomarker of cardiovascular and renal function.
    Morgenthaler NG
    Congest Heart Fail; 2010 Jul; 16 Suppl 1():S37-44. PubMed ID: 20653710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copeptin (C-terminal pro arginine-vasopressin) is an independent long-term prognostic marker in heart failure with reduced ejection fraction.
    Pozsonyi Z; Förhécz Z; Gombos T; Karádi I; Jánoskuti L; Prohászka Z
    Heart Lung Circ; 2015 Apr; 24(4):359-67. PubMed ID: 25618448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Copeptin Blood Content as a Diagnostic Marker of Chronic Kidney Disease.
    Niemczyk S; Niemczyk L; Żmudzki W; Saracyn M; Czarzasta K; Szamotulska K; Cudnoch-Jędrzejewska A
    Adv Exp Med Biol; 2018; 1096():83-91. PubMed ID: 29572679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid rule out of myocardial infarction with the use of copeptin as a biomarker for cardiac injury.
    Jayasinghe R; Narasimhan S; Tran TH; Paskaranandavadivel A
    Intern Med J; 2014 Sep; 44(9):921-4. PubMed ID: 25201424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischaemic stroke.
    Tu WJ; Dong X; Zhao SJ; Yang DG; Chen H
    J Neuroendocrinol; 2013 Sep; 25(9):771-8. PubMed ID: 23701638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction).
    Maisel A; Mueller C; Neath SX; Christenson RH; Morgenthaler NG; McCord J; Nowak RM; Vilke G; Daniels LB; Hollander JE; Apple FS; Cannon C; Nagurney JT; Schreiber D; deFilippi C; Hogan C; Diercks DB; Stein JC; Headden G; Limkakeng AT; Anand I; Wu AHB; Papassotiriou J; Hartmann O; Ebmeyer S; Clopton P; Jaffe AS; Peacock WF
    J Am Coll Cardiol; 2013 Jul; 62(2):150-160. PubMed ID: 23643595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High sensitivity troponin in cardiovascular disease. Is there more than a marker of myocardial death?
    Tsounis D; Deftereos S; Bouras G; Giannopoulos G; Anatoliotakis N; Raisakis K; Kossyvakis C; Cleman MW
    Curr Top Med Chem; 2013; 13(2):201-15. PubMed ID: 23470078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure.
    Stoiser B; Mörtl D; Hülsmann M; Berger R; Struck J; Morgenthaler NG; Bergmann A; Pacher R
    Eur J Clin Invest; 2006 Nov; 36(11):771-8. PubMed ID: 17032344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicentre, randomized, controlled open-label trial to compare an Accelerated Rule-Out protocol using combined prehospital copeptin and in-hospital high sensitive troponin with standard rule-out in patients suspected of acute Myocardial Infarction - the AROMI trial.
    Pedersen CK; Stengaard C; Søndergaard H; Dodt KK; Hjort J; Bøtker MT; Terkelsen CJ
    Trials; 2018 Dec; 19(1):683. PubMed ID: 30541594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender and renal function influence plasma levels of copeptin in healthy individuals.
    Bhandari SS; Loke I; Davies JE; Squire IB; Struck J; Ng LL
    Clin Sci (Lond); 2009 Feb; 116(3):257-63. PubMed ID: 18647134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the association of serum sodium with mortality in patients with type 2 diabetes explained by copeptin or NT-proBNP? (ZODIAC-46).
    Riphagen IJ; Logtenberg SJ; Groenier KH; van Hateren KJ; Landman GW; Struck J; Navis G; Kootstra-Ros JE; Kema IP; Bilo HJ; Kleefstra N; Bakker SJ
    Atherosclerosis; 2015 Sep; 242(1):179-85. PubMed ID: 26201002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Value of Copeptin in Chronic Kidney Disease: From General Population to End-Stage Renal Disease.
    Golembiewska E; Machowska A; Stenvinkel P; Lindholm B
    Curr Protein Pept Sci; 2017; 18(12):1232-1243. PubMed ID: 28714397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes.
    Velho G; Ragot S; El Boustany R; Saulnier PJ; Fraty M; Mohammedi K; Fumeron F; Potier L; Marre M; Hadjadj S; Roussel R
    Cardiovasc Diabetol; 2018 Aug; 17(1):110. PubMed ID: 30071874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.